PRDM5 and esophageal squamous cell carcinoma: Multivariate analysis revealed the independent prognostic factors for ESCC patients were expression of PRDM5 (HR: 2.626, 95%CI: 1.824–3.781; P < 0.001), T stage (HR: 0.719, 95%CI: 0.533–0.969; P = 0.0.03), TNM stages (HR: 0.657, 95%CI: 0.49–0.881; P < 0.001), and vascular invasion (HR: 0.694, 95%CI: 0.493–0.976; P = 0.0.036) (Table 4).